Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENT OF OPERATIONS

v3.6.0.2
CONSOLIDATED STATEMENT OF OPERATIONS - USD ($)
$ in Thousands
6 Months Ended 12 Months Ended
Dec. 31, 2015
Dec. 31, 2016
Jun. 30, 2015
Jun. 30, 2014
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS        
Revenue $ 8,979 $ 14,198 $ 9,871 $ 825
Operating expenses        
Research and development (25,472) (63,789) (24,137) (9,575)
General and administrative (9,917) (23,208) (10,375) (2,771)
Total operating expenses (including purchases from related parties, net of reimbursements, of $2,067, $1,609, $2,443 and $2,018) (35,389) (86,997) (34,512) (12,346)
Operating loss (26,410) (72,799) (24,641) (11,521)
Interest income 489 1,110 504  
Other (expense) income, net 2,866 1,002 2,323 (5)
Loss before income taxes (23,055) (70,687) (21,814) (11,526)
Income taxes 55 (892) (244) (75)
Net loss (23,000) (71,579) (22,058) (11,601)
Deemed dividend on convertible preferred shares     (14,735)  
Net loss attributable to ordinary shareholders $ (23,000) $ (71,579) $ (36,793) $ (11,601)
Net loss per ordinary share basic and diluted (Note 2) (in dollars per share) $ (0.05) $ (0.17) $ (0.17) $ (0.08)
Weighted average shares outstanding, basic and diluted (in shares) 424,711,900 424,713,997 214,704,593 148,335,529